EiPLA, also known as N-ethyl-N-isopropyllysergamide or as lysergic acid ethylisopropylamide, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is an isomer of ETH-LAD.
Use and effects EiPLA has been identified in blotter containing doses of 86 to 97μg base equivalent per tab. Blotter containing 200μg per tab has also been described. Anecdotal reports suggest that EiPLA produces psychedelic effects but is less potent than LSD.
Interactions
Pharmacology Pharmacodynamics In drug discrimination tests in rodents, EiPLA was found to have approximately half the potency of LSD.
Chemistry Analogues Analogues of EiPLA include MiPLA, LAMPA (MPLA), EPLA, EcPLA, and ETFELA, among others.
History EiPLA was first described in the scientific literature by David E. Nichols and colleagues by at least 1994. It appears to have emerged as a novel designer drug by 2019.
See also Substituted lysergamide Lizard Labs
References
External links EiPLA - Isomer Design The Big & Dandy EiPLA Thread - Bluelight